RK Pharma, Complex Sterile Injectables CDMO, Secures Investment from Signet Healthcare Partners

PEARL RIVER, NEW YORK – RK Pharma Inc. (“RK Pharma”), a vertically-integrated specialty Contract Development and Manufacturing Organization (“CDMO”), announced a $25 million growth investment from Signet Healthcare Partners (“Signet”) and affiliates, a New York-based healthcare private equity firm. This strategic investment will support RK Pharma’s expansion of its sterile manufacturing footprint and accelerate key growth initiatives.

Founded in 2003, RK Pharma develops, manufactures, and commercializes a broad portfolio of complex injectable pharmaceuticals, including oncology, long-acting, and device-integrated products, across multiple dosage forms such as solutions, suspensions, and nano-suspensions. The Company’s end-to-end capabilities—from active pharmaceutical ingredient (“API”) development to finished dose manufacturing—position it as a differentiated CDMO partner in the U.S. and global markets.

This transaction marks Signet’s third partnership with RK Pharma’s Founder and Chief Executive Officer, Dr. Ravishanker Kovi, underscoring a longstanding and successful relationship across multiple pharmaceutical platforms.

“Ravi has consistently built innovative, high-quality pharmaceutical companies addressing critical needs in the sterile and complex injectable markets,” said James Gale, Managing Director at Signet Healthcare Partners. “We’re proud to continue our partnership with him and the RK Pharma team as they scale this platform to meet the growing demand for sophisticated sterile manufacturing solutions.”

Dr. Ravishanker Kovi, Chief Executive Officer of RK Pharma, added, “Signet continues to be a trusted partner. Their deep sector focus and hands-on approach make them an ideal collaborator as we execute the next phase of RK Pharma’s growth and expand our U.S. manufacturing capabilities.”

Sidley Austin LLP, Troutman Pepper Locke, and Sheppard, Mullin, Richter & Hampton LLP served as legal advisors to the transaction

About RK Pharma Inc

RK Pharma Inc is a privately held U.S. based Company that focuses on the development, manufacturing and commercialization of high quality and affordable generic pharmaceutical products, including APIs, intermediates, finished dose formulations, and complex injectables. For more information, visit www.rkpharmainc.com.

About Signet Healthcare Partners

Signet Healthcare Partners is a New York-based growth equity firm focused on building leading companies across the pharmaceutical, CDMO, and medical device sectors. The firm invests in commercial-stage healthcare businesses and partners closely with management teams to accelerate growth and operational excellence. Over its 25-year history, Signet has raised more than $600 million and invested in over 55 healthcare companies. For more information, visit www.signethealthcarepartners.com.

Contacts

RK Pharma Inc
CustomerService@rkpharmainc.com